Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

Por Lin, Feng, Kaminski, Henry J., Conti-Fine, Bianca M., Wang, Wei, Richmonds, Chelliah, Medof, M. Edward
Publicado em 2002

Novel Complement Inhibitor Limits Severity of Experimentally Myasthenia Gravis

Por Soltys, Jindrich, Kusner, Linda L., Young, Andrew, Richmonds, Chelliah, Hatala, Denise, Gong, Bendi, Shanmugavel, Vaithesh, Kaminski, Henry J.
Publicado em 2009